Newsfeeds Archive - Page 30 of 56

2 minute read

Want To Become A Psychedelic-Assisted Therapist? This Company Offers A ‘Pathway’ Course

March 27, 7:01 PM

Mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF) is launching a collection of psychedelic-assisted therapist (PAT) training courses for practitioners with multi-modal teaching methods.

NUMIF

3 minute read

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More

By Lara Goldstein

March 27, 6:39 PM

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses

ATAI

2 minute read

Silo Pharma To Patent Novel Ketamine-Based Treatment For Chronic Condition

By Lara Goldstein

March 27, 3:19 PM

Biopharma company Silo Pharma Inc.

SILO

2 minute read

Atai Life Sciences Hopes Hercules Can Help ‘Sustain’ Operations Until 2026

By Lara Goldstein

March 24, 1:32 PM

Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show:

ATAI

1 minute read

FSD Pharma’s Australian Entity To Proceed With Phase I Trial For Major Depressive Disorder

By Lara Goldstein

March 23, 7:21 PM

Biotech company FSD Pharma Inc. (NASDAQ: HUGE)’s Australian business FSD Pharma Australia Pty Ltd. has been approved by the Alfred Ethics Committee to begin a Phase 1 clinical trial of next-gen drug candidate Lucid-201, or Lucid-Psych, for cases of Major Depressive Disorder (MDD.)

HUGE

1 minute read

High Times And Lucy Scientific Discovery Launching Amanita Muscaria Mushrooms Product

By Lara Goldstein

March 23, 4:22 PM

Psychedelics producer Lucy Scientific Discovery Inc. (NASDAQ: LSDI) is launching a new brand of products containing unscheduled psychoactive compounds, soon available for sale in the U.S. and all other parts of the world where legal.

LSDI